<div id="readability-page-1"><div><ul> <li>On December 18, 2025, VeriSign’s Executive Chairman, President, and CEO D Bidzos sold 9,000 company shares, contributing to a year of substantial insider selling highlighted in recent SEC filings.</li> <li>These transactions, set against VeriSign’s role in operating critical internet infrastructure, draw attention to how leadership’s trading activity aligns with its long-term outlook on the core domain registry business.</li> <li>We’ll now explore how this pattern of insider selling, particularly by the CEO, may influence VeriSign’s existing investment narrative and risk considerations.</li> </ul><p>Rare earth metals are the new gold rush. Find out which 35 stocks are leading the charge.</p><h2>VeriSign Investment Narrative Recap</h2><p>To own VeriSign, you need to believe its role in core internet infrastructure will keep supporting steady domain-related cash flows, even with modest growth expectations and high leverage on the balance sheet. The recent pattern of insider selling, including D Bidzos’ 9,000 share sale and a clear tilt toward insider sells, does not appear to alter the near term focus on domain base trends as the key catalyst or the company’s elevated balance sheet risk.</p> <p>The most relevant recent announcement beside insider activity is VeriSign’s ongoing capital return, including regular US$0.77 quarterly dividends and sizable share buybacks. This return of cash, alongside updated 2025 revenue and operating income guidance, frames insider selling against a backdrop of management signaling confidence through dividends and repurchases, while investors weigh slower forecast growth against the stability of the core registry business.</p> <p>Yet behind the steady dividends, investors should be aware of the combination of high debt, negative equity and concentrated insider selling...</p> <p>Read the full narrative on VeriSign (it's free!)</p><p>VeriSign's narrative projects $1.9 billion revenue and $1.0 billion earnings by 2028. This requires 6.4% yearly revenue growth and an earnings increase of about $200 million from $799.5 million today.</p><p>Uncover how VeriSign's forecasts yield a $295.50 fair value, a 21% upside to its current price.</p><h2>Exploring Other Perspectives</h2><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8e5424e3-5aa5-4e4e-908e-3aba82794f5a/chart/quote-price?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/8e5424e3-5aa5-4e4e-908e-3aba82794f5a/chart/quote-price"/><figcaption>VRSN 1-Year Stock Price Chart</figcaption></figure> <p>Eight members of the Simply Wall St Community currently estimate VeriSign’s fair value between US$220 and US$340, reflecting a wide spread of individual views. Set against this, the heavy insider selling record invites you to weigh balance sheet risks and insider behavior alongside those community forecasts before forming your own view.</p><p>Explore 8 other fair value estimates on VeriSign - why the stock might be worth 10% less than the current price!</p><h2>Build Your Own VeriSign Narrative</h2><p>Disagree with existing narratives? Create your own in under 3 minutes - extraordinary investment returns rarely come from following the herd.</p><ul><li>A great starting point for your VeriSign research is our analysis highlighting 4 key rewards and 3 important warning signs that could impact your investment decision.</li><li>Our free VeriSign research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate VeriSign's overall financial health at a glance.</li></ul><h2>Interested In Other Possibilities?</h2><p>Our top stock finds are flying under the radar-for now. Get in early:</p><ul><li>Uncover the next big thing with financially sound penny stocks that balance risk and reward.</li><li>Explore 28 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.</li><li>AI is about to change healthcare. These 29 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data     and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your     financial situation. We aim to bring you long-term focused analysis driven by fundamental data.     Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.     Simply Wall St has no position in any stocks mentioned.</em></p><div><p>Mobile Infrastructure for Defense and Disaster</p><p>The next wave in robotics isn't humanoid. Its fully autonomous towers delivering 5G, ISR, and radar in under 30 minutes, anywhere.</p><p>Get the investor briefing before the next round of contracts</p><p><span>Sponsored On Behalf of CiTech</span></p></div></div></div>

VRSN

<p>VeriSign's CEO D Bidzos sold 9,000 shares, contributing to significant insider selling in 2025. This activity raises questions about leadership's confidence in the company's long-term outlook. Despite insider selling, VeriSign continues to return capital through dividends and share buybacks. The company's financial projections include $1.9 billion in revenue and $1.0 billion in earnings by 2028, requiring 6.4% annual revenue growth. Investors should consider balance sheet risks and insider behavior when evaluating VeriSign's investment potential.</p>

Will CEO D Bidzos’s Ongoing Stock Sales Reshape VeriSign’s (VRSN) Long‑Term Confidence Narrative?